IDH1 and glioma: However, the major influence of the IDH mutation results from supraphysiologic levels of intracellular and extracellular D-2-HG that act as a competitive inhibitor of a wide variety of Fe(II)-dependent and α-KG–dependent dioxygenases in glioma cells and their microenvironment (10, 11).